Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Anti-Counterfeiting Public Meeting To Display Current Technology

Executive Summary

FDA's public meeting on drug counterfeiting Oct. 15 will feature vendor displays of current anti-counterfeiting technology
Advertisement

Related Content

FDA Anti-Counterfeit Technology Policy Head Is Ex-CMS Staffer Rudolf
FDA Anti-Counterfeit Technology Policy Head Is Ex-CMS Staffer Rudolf
FDA Counterfeit Report Seeks “Electronic Pedigree” To Aid Drug Tracking
FDA Counterfeit Report Seeks “Electronic Pedigree” To Aid Drug Tracking
FDA Counterfeiting Task Force Has Standardized Reporting In Its Sights
FDA Counterfeiting Task Force Has Standardized Reporting In Its Sights
Rx Counterfeits: FDA Says Serono Serostim Tracking Is Effective Solution
Rx Counterfeits: FDA Says Serono Serostim Tracking Is Effective Solution
FDA Counterfeiting Task Force To Look At Tighter Wholesaler Licensing
Advertisement
UsernamePublicRestriction

Register

PS042419

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel